nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Hypertensive crisis—Sorafenib—liver cancer	0.0547	0.0813	CcSEcCtD
Phenylephrine—Ischaemia—Sorafenib—liver cancer	0.0416	0.0618	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Sorafenib—liver cancer	0.0189	0.0281	CcSEcCtD
Phenylephrine—Skin necrosis—Epirubicin—liver cancer	0.0161	0.0239	CcSEcCtD
Phenylephrine—Sensitisation—Epirubicin—liver cancer	0.0157	0.0233	CcSEcCtD
Phenylephrine—Blood pressure increased—Sorafenib—liver cancer	0.0152	0.0226	CcSEcCtD
Phenylephrine—Skin necrosis—Doxorubicin—liver cancer	0.0149	0.0221	CcSEcCtD
Phenylephrine—Sensitisation—Doxorubicin—liver cancer	0.0145	0.0216	CcSEcCtD
Phenylephrine—Skin exfoliation—Sorafenib—liver cancer	0.0145	0.0215	CcSEcCtD
Phenylephrine—Abdominal pain upper—Sorafenib—liver cancer	0.0101	0.015	CcSEcCtD
Phenylephrine—Lacrimation—Epirubicin—liver cancer	0.00954	0.0142	CcSEcCtD
Phenylephrine—Lacrimation—Doxorubicin—liver cancer	0.00883	0.0131	CcSEcCtD
Phenylephrine—Keratitis—Epirubicin—liver cancer	0.00865	0.0129	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Sorafenib—liver cancer	0.00837	0.0124	CcSEcCtD
Phenylephrine—Myocardial infarction—Sorafenib—liver cancer	0.00832	0.0124	CcSEcCtD
Phenylephrine—Keratitis—Doxorubicin—liver cancer	0.008	0.0119	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00758	0.0113	CcSEcCtD
Phenylephrine—Cardiac disorder—Sorafenib—liver cancer	0.00707	0.0105	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00701	0.0104	CcSEcCtD
Phenylephrine—Stinging—Epirubicin—liver cancer	0.00692	0.0103	CcSEcCtD
Phenylephrine—Angiopathy—Sorafenib—liver cancer	0.00692	0.0103	CcSEcCtD
Phenylephrine—Immune system disorder—Sorafenib—liver cancer	0.00689	0.0102	CcSEcCtD
Phenylephrine—Mediastinal disorder—Sorafenib—liver cancer	0.00687	0.0102	CcSEcCtD
Phenylephrine—Arrhythmia—Sorafenib—liver cancer	0.00681	0.0101	CcSEcCtD
Phenylephrine—Mental disorder—Sorafenib—liver cancer	0.00668	0.00992	CcSEcCtD
Phenylephrine—Dysgeusia—Sorafenib—liver cancer	0.0065	0.00965	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—liver cancer	0.00643	0.00955	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—liver cancer	0.00641	0.00952	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—liver cancer	0.00621	0.00923	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—liver cancer	0.00609	0.00904	CcSEcCtD
Phenylephrine—Syncope—Sorafenib—liver cancer	0.00595	0.00884	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—liver cancer	0.00595	0.00884	CcSEcCtD
Phenylephrine—Loss of consciousness—Sorafenib—liver cancer	0.00583	0.00867	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—liver cancer	0.00578	0.00859	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00575	0.00854	CcSEcCtD
Phenylephrine—Hypertension—Sorafenib—liver cancer	0.00573	0.00851	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—liver cancer	0.00568	0.00844	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—liver cancer	0.00563	0.00837	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00561	0.00834	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—liver cancer	0.00536	0.00796	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—liver cancer	0.00535	0.00795	CcSEcCtD
Phenylephrine—Shock—Sorafenib—liver cancer	0.00533	0.00792	CcSEcCtD
Phenylephrine—Nervous system disorder—Sorafenib—liver cancer	0.00531	0.00789	CcSEcCtD
Phenylephrine—Skin disorder—Sorafenib—liver cancer	0.00526	0.00782	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—liver cancer	0.00525	0.00781	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—liver cancer	0.00499	0.00742	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—liver cancer	0.00496	0.00736	CcSEcCtD
Phenylephrine—Dyspnoea—Sorafenib—liver cancer	0.00483	0.00717	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00468	0.00695	CcSEcCtD
Phenylephrine—Pain—Sorafenib—liver cancer	0.00463	0.00688	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—liver cancer	0.00462	0.00686	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—liver cancer	0.00451	0.0067	CcSEcCtD
Phenylephrine—Urticaria—Sorafenib—liver cancer	0.0043	0.00639	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—liver cancer	0.00417	0.0062	CcSEcCtD
Phenylephrine—Hypersensitivity—Sorafenib—liver cancer	0.00399	0.00593	CcSEcCtD
Phenylephrine—Pruritus—Sorafenib—liver cancer	0.00383	0.00569	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—liver cancer	0.00372	0.00553	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—liver cancer	0.00372	0.00553	CcSEcCtD
Phenylephrine—Dizziness—Sorafenib—liver cancer	0.00358	0.00532	CcSEcCtD
Phenylephrine—Vomiting—Sorafenib—liver cancer	0.00344	0.00512	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00344	0.00511	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—liver cancer	0.00344	0.00511	CcSEcCtD
Phenylephrine—Rash—Sorafenib—liver cancer	0.00341	0.00507	CcSEcCtD
Phenylephrine—Dermatitis—Sorafenib—liver cancer	0.00341	0.00507	CcSEcCtD
Phenylephrine—Headache—Sorafenib—liver cancer	0.00339	0.00504	CcSEcCtD
Phenylephrine—Nausea—Sorafenib—liver cancer	0.00322	0.00478	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—liver cancer	0.00287	0.00426	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—liver cancer	0.00272	0.00403	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—liver cancer	0.00265	0.00394	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—liver cancer	0.00261	0.00388	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—liver cancer	0.00256	0.0038	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—liver cancer	0.00254	0.00378	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—liver cancer	0.00254	0.00377	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—liver cancer	0.00252	0.00374	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—liver cancer	0.00251	0.00373	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—liver cancer	0.00247	0.00367	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—liver cancer	0.00242	0.00359	CcSEcCtD
Phenylephrine—Tension—Epirubicin—liver cancer	0.00241	0.00358	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—liver cancer	0.0024	0.00357	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—liver cancer	0.00238	0.00354	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—liver cancer	0.00237	0.00351	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—liver cancer	0.00235	0.0035	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—liver cancer	0.00235	0.00349	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—liver cancer	0.00233	0.00346	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—liver cancer	0.00231	0.00343	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—liver cancer	0.00228	0.00339	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—liver cancer	0.00225	0.00335	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—liver cancer	0.00223	0.00331	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—liver cancer	0.00222	0.0033	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—liver cancer	0.0022	0.00327	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—liver cancer	0.0022	0.00327	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—liver cancer	0.00217	0.00322	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—liver cancer	0.00216	0.0032	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—liver cancer	0.00214	0.00318	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—liver cancer	0.00212	0.00315	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—liver cancer	0.00209	0.0031	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—liver cancer	0.00209	0.0031	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00207	0.00308	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—liver cancer	0.00204	0.00302	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—liver cancer	0.00201	0.00298	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—liver cancer	0.00199	0.00296	CcSEcCtD
Phenylephrine—Shock—Epirubicin—liver cancer	0.00197	0.00293	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—liver cancer	0.00196	0.00292	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—liver cancer	0.00196	0.00291	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—liver cancer	0.00195	0.0029	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—liver cancer	0.00194	0.00289	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—liver cancer	0.00193	0.00287	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—liver cancer	0.00193	0.00287	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00192	0.00285	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—liver cancer	0.00182	0.00271	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—liver cancer	0.00182	0.0027	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—liver cancer	0.00181	0.00269	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—liver cancer	0.0018	0.00267	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—liver cancer	0.0018	0.00267	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—liver cancer	0.00179	0.00266	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—liver cancer	0.00178	0.00265	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00173	0.00257	CcSEcCtD
Phenylephrine—Pain—Epirubicin—liver cancer	0.00171	0.00254	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—liver cancer	0.00166	0.00247	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—liver cancer	0.00165	0.00245	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.0016	0.00238	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—liver cancer	0.00159	0.00236	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—liver cancer	0.00158	0.00235	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—liver cancer	0.00147	0.00219	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—liver cancer	0.00147	0.00219	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—liver cancer	0.00142	0.0021	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—liver cancer	0.00136	0.00203	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—liver cancer	0.00132	0.00197	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—liver cancer	0.00131	0.00195	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—liver cancer	0.00127	0.00189	CcSEcCtD
Phenylephrine—Rash—Epirubicin—liver cancer	0.00126	0.00187	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—liver cancer	0.00126	0.00187	CcSEcCtD
Phenylephrine—Headache—Epirubicin—liver cancer	0.00125	0.00186	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—liver cancer	0.00122	0.00182	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—liver cancer	0.00119	0.00177	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—liver cancer	0.00118	0.00175	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—liver cancer	0.00117	0.00173	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—liver cancer	0.00117	0.00173	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—liver cancer	0.00116	0.00172	CcSEcCtD
Phenylephrine—Epinephrine—TNF—liver cancer	0.0011	0.525	CrCbGaD
Phenylephrine—Nausea—Doxorubicin—liver cancer	0.0011	0.00163	CcSEcCtD
Phenylephrine—Isoprenaline—CYP1A1—liver cancer	0.000997	0.475	CrCbGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CSF2—liver cancer	0.000219	0.000673	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—PIK3CA—liver cancer	0.000218	0.000673	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TAT—liver cancer	0.000218	0.000672	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000215	0.000661	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.000213	0.000655	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP2E1—liver cancer	0.000211	0.000651	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR4—liver cancer	0.00021	0.000648	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PRKCE—liver cancer	0.000205	0.000632	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FST—liver cancer	0.000204	0.000629	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—HRAS—liver cancer	0.000204	0.000628	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000204	0.000627	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PRKCE—liver cancer	0.000201	0.000618	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADAM17—liver cancer	0.0002	0.000617	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CSF2—liver cancer	0.0002	0.000615	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYCS—liver cancer	0.000198	0.000609	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000195	0.000602	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TRIO—liver cancer	0.000195	0.0006	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000195	0.0006	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GGT1—liver cancer	0.000194	0.000597	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GOT1—liver cancer	0.000194	0.000597	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—F2—liver cancer	0.000189	0.000582	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PSMD10—liver cancer	0.000188	0.00058	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PSMA4—liver cancer	0.000188	0.00058	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR4—liver cancer	0.000187	0.000576	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PRKCE—liver cancer	0.000182	0.000561	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CSF2—liver cancer	0.000181	0.000559	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CG—liver cancer	0.000181	0.000557	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000181	0.000557	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CSF2—liver cancer	0.000178	0.000547	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTP1—liver cancer	0.000174	0.000537	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000173	0.000533	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HMOX1—liver cancer	0.000172	0.000529	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—F2—liver cancer	0.000172	0.000528	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADAM17—liver cancer	0.000166	0.000512	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CG—liver cancer	0.000164	0.000506	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CSF2—liver cancer	0.000161	0.000496	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000161	0.000495	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—liver cancer	0.00016	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CD—liver cancer	0.000159	0.000489	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—F2—liver cancer	0.000157	0.000483	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PSMA4—liver cancer	0.000156	0.000482	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PSMD10—liver cancer	0.000156	0.000482	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A1—liver cancer	0.000152	0.000467	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CG—liver cancer	0.00015	0.000462	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CPT1B—liver cancer	0.000148	0.000457	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GLUL—liver cancer	0.000148	0.000457	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADAM17—liver cancer	0.000148	0.000455	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCE—liver cancer	0.000146	0.00045	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CD—liver cancer	0.000144	0.000444	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NR1H4—liver cancer	0.000143	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—F2—liver cancer	0.000142	0.000438	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—liver cancer	0.000142	0.000436	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTA3—liver cancer	0.000141	0.000433	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—F2—liver cancer	0.000139	0.000429	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PSMA4—liver cancer	0.000139	0.000428	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PSMD10—liver cancer	0.000139	0.000428	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARA—liver cancer	0.000139	0.000428	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CB—liver cancer	0.000139	0.000427	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF2—liver cancer	0.000138	0.000426	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CG—liver cancer	0.000136	0.00042	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CG—liver cancer	0.000133	0.00041	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CD—liver cancer	0.000132	0.000406	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CSF2—liver cancer	0.000129	0.000398	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—RAF1—liver cancer	0.000129	0.000397	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTA4—liver cancer	0.000129	0.000396	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—H2AFX—liver cancer	0.000127	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2—liver cancer	0.000127	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—F2—liver cancer	0.000126	0.000389	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CB—liver cancer	0.000126	0.000387	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000126	0.000387	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTA2—liver cancer	0.000125	0.000386	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCE—liver cancer	0.000121	0.000373	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CG—liver cancer	0.000121	0.000373	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTA1—liver cancer	0.000121	0.000372	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CD—liver cancer	0.00012	0.000369	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAT2—liver cancer	0.00012	0.000368	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—liver cancer	0.000119	0.000366	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CD—liver cancer	0.000117	0.000361	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—liver cancer	0.000116	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TERT—liver cancer	0.000115	0.000354	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000115	0.000354	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CB—liver cancer	0.000115	0.000354	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—liver cancer	0.000115	0.000353	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—liver cancer	0.000115	0.000353	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALDOB—liver cancer	0.000115	0.000353	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CRABP1—liver cancer	0.000109	0.000337	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCE—liver cancer	0.000108	0.000331	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CSF2—liver cancer	0.000107	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RAF1—liver cancer	0.000107	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—liver cancer	0.000106	0.000328	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—H2AFX—liver cancer	0.000106	0.000325	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—liver cancer	0.000106	0.000325	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—liver cancer	0.000105	0.000324	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK14—liver cancer	0.000105	0.000322	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—liver cancer	0.000105	0.000322	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—liver cancer	0.000104	0.000322	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—liver cancer	0.000103	0.000318	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—liver cancer	0.000103	0.000316	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—liver cancer	0.000102	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—liver cancer	0.000102	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—F2—liver cancer	0.000101	0.000312	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.85e-05	0.000303	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APC—liver cancer	9.7e-05	0.000299	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—liver cancer	9.7e-05	0.000299	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—liver cancer	9.59e-05	0.000295	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HPGDS—liver cancer	9.56e-05	0.000294	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—liver cancer	9.56e-05	0.000294	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CSF2—liver cancer	9.52e-05	0.000293	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.51e-05	0.000293	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RAF1—liver cancer	9.5e-05	0.000293	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—H2AFX—liver cancer	9.39e-05	0.000289	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—liver cancer	9.38e-05	0.000289	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	9.28e-05	0.000286	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—liver cancer	9.12e-05	0.000281	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—liver cancer	9.11e-05	0.000281	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—liver cancer	8.74e-05	0.000269	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK14—liver cancer	8.68e-05	0.000267	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.66e-05	0.000267	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.55e-05	0.000263	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—liver cancer	8.53e-05	0.000263	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PSMA4—liver cancer	8.52e-05	0.000262	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PSMD10—liver cancer	8.52e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—liver cancer	8.52e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—liver cancer	8.52e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—liver cancer	8.49e-05	0.000261	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—liver cancer	8.45e-05	0.00026	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—liver cancer	8.43e-05	0.00026	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—F2—liver cancer	8.41e-05	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—liver cancer	8.35e-05	0.000257	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT2—liver cancer	8.29e-05	0.000255	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	8.05e-05	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APC—liver cancer	8.05e-05	0.000248	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2E1—liver cancer	7.79e-05	0.00024	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—liver cancer	7.76e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK14—liver cancer	7.71e-05	0.000237	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—liver cancer	7.67e-05	0.000236	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAF1—liver cancer	7.61e-05	0.000234	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—liver cancer	7.57e-05	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—liver cancer	7.57e-05	0.000233	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.55e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—F2—liver cancer	7.47e-05	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—liver cancer	7.43e-05	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—liver cancer	7.43e-05	0.000229	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYCS—liver cancer	7.29e-05	0.000225	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GGT1—liver cancer	7.16e-05	0.00022	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT1—liver cancer	7.16e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APC—liver cancer	7.15e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	7.15e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—liver cancer	7.1e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	7.08e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	7.01e-05	0.000216	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	7e-05	0.000216	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	6.98e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—liver cancer	6.93e-05	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	6.9e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—liver cancer	6.84e-05	0.00021	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—liver cancer	6.83e-05	0.00021	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—liver cancer	6.79e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—liver cancer	6.72e-05	0.000207	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—liver cancer	6.65e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUN—liver cancer	6.64e-05	0.000204	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	6.59e-05	0.000203	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—liver cancer	6.46e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	6.44e-05	0.000198	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—liver cancer	6.43e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	6.37e-05	0.000196	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—liver cancer	6.34e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAF1—liver cancer	6.32e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	6.29e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—liver cancer	6.28e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—liver cancer	6.27e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	6.23e-05	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	6.22e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—liver cancer	6.17e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	6.17e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—liver cancer	6.15e-05	0.000189	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—liver cancer	5.91e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—liver cancer	5.89e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—liver cancer	5.8e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	5.79e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—liver cancer	5.74e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	5.73e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—liver cancer	5.67e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—liver cancer	5.67e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	5.65e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—liver cancer	5.64e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAF1—liver cancer	5.61e-05	0.000173	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—liver cancer	5.6e-05	0.000172	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—liver cancer	5.56e-05	0.000171	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—liver cancer	5.52e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUN—liver cancer	5.51e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	5.48e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—liver cancer	5.48e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	5.47e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—liver cancer	5.36e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	5.34e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—liver cancer	5.34e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—liver cancer	5.32e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	5.23e-05	0.000161	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—liver cancer	5.22e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	5.21e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	5.2e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	5.14e-05	0.000158	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARA—liver cancer	5.12e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	5.09e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—liver cancer	5.04e-05	0.000155	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—liver cancer	5.03e-05	0.000155	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—liver cancer	5.01e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—liver cancer	4.93e-05	0.000152	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—liver cancer	4.91e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUN—liver cancer	4.9e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	4.86e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	4.81e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—liver cancer	4.77e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—liver cancer	4.76e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	4.75e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	4.63e-05	0.000143	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	4.62e-05	0.000142	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.6e-05	0.000142	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—liver cancer	4.54e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	4.53e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—liver cancer	4.43e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	4.42e-05	0.000136	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—liver cancer	4.39e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—liver cancer	4.38e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	4.28e-05	0.000132	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—liver cancer	4.23e-05	0.00013	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—liver cancer	4.23e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—liver cancer	4.19e-05	0.000129	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—liver cancer	4.09e-05	0.000126	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—liver cancer	4.01e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—liver cancer	3.93e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	3.93e-05	0.000121	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.86e-05	0.000119	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—liver cancer	3.81e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	3.76e-05	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—liver cancer	3.7e-05	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—liver cancer	3.64e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—liver cancer	3.64e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—liver cancer	3.48e-05	0.000107	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—liver cancer	3.36e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	3.34e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—liver cancer	3.33e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—liver cancer	3.23e-05	9.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—liver cancer	3.09e-05	9.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—liver cancer	3.07e-05	9.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—liver cancer	2.96e-05	9.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—liver cancer	2.73e-05	8.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.05e-05	6.31e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—liver cancer	1.67e-05	5.15e-05	CbGpPWpGaD
